tiprankstipranks
Rosetta Genomics Ltd (ROSGQ)
OTHER OTC:ROSGQ
US Market

Rosetta Genomics (ROSGQ) Financial Statements

57 Followers

Rosetta Genomics Financial Overview

Rosetta Genomics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Rosetta Genomics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 17Dec 16Sep 16Jun 16Mar 16
Income Statement-
Total Revenue$ 870.00K$ 2.02M$ 2.20M$ 404.00K$ 2.60M
Gross Profit$ 301.00K$ 17.00K$ 410.00K$ -92.00K$ 945.00K
EBIT$ -1.37M$ -4.89M$ -3.94M$ -3.25M$ -4.01M
EBITDA$ -1.37M$ -4.89M$ -3.94M$ -3.25M$ -4.01M
Net Income Common Stockholders$ -2.07M$ -4.84M$ -3.97M$ -3.39M$ -4.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.32M$ 6.16M$ 5.42M$ 8.05M$ 11.90M
Total Assets$ 6.21M$ 11.96M$ 12.63M$ 15.79M$ 19.26M
Total Debt$ 2.45M$ 3.79M$ 134.00K$ 147.00K$ 0.00
Net Debt$ 1.12M$ -2.37M$ -5.29M$ -7.91M$ -11.90M
Total Liabilities$ 5.11M$ 7.54M$ 3.71M$ 3.15M$ 3.45M
Stockholders Equity$ 1.10M$ 4.42M$ 8.92M$ 12.65M$ 15.81M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Rosetta Genomics Earnings and Revenue History

Rosetta Genomics Debt to Assets

Rosetta Genomics Cash Flow

Rosetta Genomics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis